310 related articles for article (PubMed ID: 31561352)
1. Color coded perfusion analysis and microcirculation imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following thermal ablative techniques of primary and secondary liver malignancies.
Rennert J; Wiesinger I; Beyer LP; Schicho A; Stroszczynski C; Wiggermann P; Jung EM
Clin Hemorheol Microcirc; 2019; 73(1):73-83. PubMed ID: 31561352
[TBL] [Abstract][Full Text] [Related]
2. Color Coded Perfusion Imaging with Contrast Enhanced Ultrasound (CEUS) for Post-Interventional Success Control Following Irreversible Electroporation (IRE) of Primary and Secondary Malignant Liver Lesions.
Rennert J; Wiesinger I; Schicho A; Wiggermann P; Stroszczynski C; Beyer LP; Jung EM
J Gastrointestin Liver Dis; 2019 Sep; 28(3):311-318. PubMed ID: 31517328
[TBL] [Abstract][Full Text] [Related]
3. Color coded perfusion imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following trans-arterial chemoembolization (TACE) of hepatocellular carcinoma.
Rennert J; Wiesinger I; Schicho A; Beyer LP; Wiggermann P; Stroszczynski C; Jung EM
PLoS One; 2019; 14(6):e0217599. PubMed ID: 31181127
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous Treatment of Malignant Liver Lesions: Evaluation of Success Using Contrast- Enhanced Ultrasound (CEUS) and Perfusion Software.
Wiesinger I; Wiggermann P; Zausig N; Beyer LP; Salzberger B; Stroszczynski C; Jung EM
Ultraschall Med; 2018 Aug; 39(4):440-447. PubMed ID: 28946152
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of integrated color-coded perfusion analysis for contrast-enhanced ultrasound (CEUS) after percutaneous interventions for malignant liver lesions: First results.
Wiesinger I; Beyer LP; Zausig N; Verloh N; Wiggermann P; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2018; 69(1-2):59-67. PubMed ID: 29758936
[TBL] [Abstract][Full Text] [Related]
6. Efficiency of contrast enhanced ultrasound for immediate assessment of ablation status after intraoperative radiofrequency ablation of hepatic malignancies.
da Silva NPB; Beyer LP; Hottenrott MC; Hackl C; Schlitt HJ; Stroszczynski C; Wiggermann P; Jung EM
Clin Hemorheol Microcirc; 2017; 66(4):357-368. PubMed ID: 28598835
[TBL] [Abstract][Full Text] [Related]
7. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers.
Bo XW; Xu HX; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K; Wang D
Br J Radiol; 2017 Oct; 90(1078):20170063. PubMed ID: 28749166
[TBL] [Abstract][Full Text] [Related]
8. Immediate evaluation and guidance of liver cancer thermal ablation by three-dimensional ultrasound/contrast-enhanced ultrasound fusion imaging.
Xu EJ; Lv SM; Li K; Long YL; Zeng QJ; Su ZZ; Zheng RQ
Int J Hyperthermia; 2018 Sep; 34(6):870-876. PubMed ID: 28847188
[TBL] [Abstract][Full Text] [Related]
9. Quantification of dynamic contrast-enhanced ultrasound (CEUS) in non-cystic breast lesions using external perfusion software.
Jung EM; Jung F; Stroszczynski C; Wiesinger I
Sci Rep; 2021 Sep; 11(1):17677. PubMed ID: 34480040
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced ultrasound improves real-time imaging of ablation region during radiofrequency ablation: preliminary results.
Wiggermann P; Zuber-Jerger I; Zausig Y; Loss M; Scherer MN; Schreyer AG; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2011; 49(1-4):43-54. PubMed ID: 22214677
[TBL] [Abstract][Full Text] [Related]
11. Color-coded perfusion analysis of CEUS for pre-interventional diagnosis of microvascularisation in cases of vascular malformations.
Teusch VI; Wohlgemuth WA; Piehler AP; Jung EM
Clin Hemorheol Microcirc; 2014; 58(1):183-93. PubMed ID: 25227194
[TBL] [Abstract][Full Text] [Related]
12. Current use of percutaneous image-guided tumor ablation for the therapy of liver tumors: lessons learned from the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR) 2018-2022.
Zensen S; Bücker A; Meetschen M; Haubold J; Opitz M; Theysohn JM; Schramm S; Jochheim L; Kasper S; Forsting M; Schaarschmidt BM
Eur Radiol; 2024 May; 34(5):3322-3330. PubMed ID: 37935847
[TBL] [Abstract][Full Text] [Related]
13. Contrast enhanced ultrasound (CEUS) with parametric imaging and time intensity curve analysis (TIC) for evaluation of the success of prostate arterial embolization (PAE) in cases of prostate hyperplasia.
Jung EM; Wertheimer T; Putz FJ; Jung F; Kammerer S; Pregler B; Luerken L; Stroszczynski C; Beyer L
Clin Hemorheol Microcirc; 2020; 76(2):143-153. PubMed ID: 32925006
[TBL] [Abstract][Full Text] [Related]
14. Quantitative perfusion analysis of hepatocellular carcinoma using dynamic contrast enhanced ultrasound (CEUS) to determine tumor microvascularization.
Schaible J; Stroszczynski C; Beyer LP; Jung EM
Clin Hemorheol Microcirc; 2019; 73(1):95-104. PubMed ID: 31561349
[TBL] [Abstract][Full Text] [Related]
15. Use of intra-procedural fusion imaging combining contrast-enhanced ultrasound using a perflubutane-based contrast agent and auto sweep three-dimensional ultrasound for guiding radiofrequency ablation and evaluating its efficacy in patients with hepatocellular carcinoma.
Sanga K; Numata K; Nihonmatsu H; Ogushi K; Fukuda H; Chuma M; Hashimoto H; Koizumi N; Maeda S
Int J Hyperthermia; 2020; 37(1):202-211. PubMed ID: 32070164
[No Abstract] [Full Text] [Related]
16. Radiofrequency ablation of liver cancers adjacent to the gallbladder without gallbladder isolation under contrast-enhanced ultrasound monitoring: a preliminary study.
Long Y; Yan R; Li K; Luo L; Zeng Q; Tan L; Zhang M; Zheng R; Xu E
Int J Hyperthermia; 2019; 36(1):139-145. PubMed ID: 30489164
[TBL] [Abstract][Full Text] [Related]
17. Role of contrast-enhanced ultrasound (CEUS) in evaluation of thermal ablation zone.
Lekht I; Gulati M; Nayyar M; Katz MD; Ter-Oganesyan R; Marx M; Cen SY; Grant E
Abdom Radiol (NY); 2016 Aug; 41(8):1511-21. PubMed ID: 26969495
[TBL] [Abstract][Full Text] [Related]
18. Identification of two distinct hereditary hemorrhagic telangiectasia patient subsets with different hepatic perfusion properties by combination of contrast-enhanced ultrasound (CEUS) with perfusion imaging quantification.
Schelker RC; Andorfer K; Putz F; Herr W; Jung EM
PLoS One; 2019; 14(4):e0215178. PubMed ID: 30973932
[TBL] [Abstract][Full Text] [Related]
19. Monitoring during hepatic radiofrequency ablation (RFA): comparison of real-time ultrasound elastography (RTE) and contrast-enhanced ultrasound (CEUS): first clinical results of 25 patients.
Wiggermann P; Brünn K; Rennert J; Loss M; Wobser H; Schreyer AG; Stroszczynski C; Jung EM
Ultraschall Med; 2013 Dec; 34(6):590-4. PubMed ID: 24132649
[TBL] [Abstract][Full Text] [Related]
20. VueBox® perfusion analysis of contrast-enhanced ultrasound (CEUS) examinations in patients with primary hyperparathyroidism for preoperative detection of parathyroid gland adenoma.
Platz Batista da Silva N; Jung EM; Jung F; Schlitt HJ; Hornung M
Clin Hemorheol Microcirc; 2018; 70(4):423-431. PubMed ID: 30347604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
